跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
MINT-INDOMETHACIN
Authorized
STANDARD
MINT-INDOMETHACIN
mint pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
98ec676d96bbae3e
Company
mint pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
98ec676d96bbae3e
Drug Approval Canada Name
MINT-INDOMETHACIN
Product Name
MINT-INDOMETHACIN
Status
Marketed
Status Date
2017-04-03
Original Market Date
2017-04-03
Din
02461811
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:08.04.92
Atc Original
M01AB01 INDOMETACIN
Atc Name
m 01 ab 01
Aig Number
0101832001
Company Name
mint pharmaceuticals inc
Company Address
6575 Davand Drive, Mississauga, Ontario, Canada, L5T 2M3
Active Ingredients
INDOMETHACIN
25 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
98ec676d96bbae3e
Type
Standard
Back to Health Canada Approvals
MINT-INDOMETHACIN - Health Canada Drug Approval Details